Genocea Financial Statements From 2010 to 2022

GGNNW -  USA Stock  

USD 0.0123  0.00  0.00%

Genocea Biosciences financial statements provide useful quarterly and yearly information to potential Genocea Biosciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Genocea Biosciences financial statements helps investors assess Genocea Biosciences' valuation, profitability, and current liquidity needs.
Genocea Biosciences does not presently have any fundamental trends for analysis.
.

Genocea Financial Statements 

 
Refresh
Check Genocea Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genocea main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Genocea financial statements analysis is a perfect complement when working with Genocea Biosciences Valuation or Volatility modules. It can also supplement various Genocea Biosciences Technical models. Please check Risk vs Return Analysis.

Genocea Market Capitalization Analysis

Genocea Biosciences' Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Market Cap 
 = 
Shares Outstanding 
X  
Share Price 
More About Market Capitalization | All Equity Analysis

Current Genocea Biosciences Market Capitalization

    
  5.72 M  
Most of Genocea Biosciences' fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Genocea Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Based on the recorded statements, the market capitalization of Genocea Biosciences is about 5.72 M. This is much higher than that of the sector and significantly higher than that of the Market Capitalization industry. The market capitalization for all United States stocks is notably lower than that of the firm.

About Genocea Biosciences Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Genocea Biosciences income statement, its balance sheet, and the statement of cash flows. Genocea Biosciences investors use historical funamental indicators, such as Genocea Biosciences's revenue or net income, to determine how well the company is positioned to perform in the future. Although Genocea Biosciences investors may use each financial statement separately, they are all related. The changes in Genocea Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Genocea Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Genocea Biosciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Genocea Biosciences. Please read more on our technical analysis and fundamental analysis pages.

Genocea Biosciences Investors Sentiment

The influence of Genocea Biosciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Genocea. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Genocea Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Genocea Biosciences' short interest history, or implied volatility extrapolated from Genocea Biosciences options trading.

Current Sentiment - GGNNW

Genocea Biosciences Investor Sentiment

Macroaxis portfolio users are indifferent in their judgment towards investing in Genocea Biosciences. What is your judgment towards investing in Genocea Biosciences? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Genocea Biosciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please check Risk vs Return Analysis. Note that the Genocea Biosciences information on this page should be used as a complementary analysis to other Genocea Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for Genocea OTC Stock analysis

When running Genocea Biosciences price analysis, check to measure Genocea Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genocea Biosciences is operating at the current time. Most of Genocea Biosciences' value examination focuses on studying past and present price action to predict the probability of Genocea Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Genocea Biosciences' price. Additionally, you may evaluate how the addition of Genocea Biosciences to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Is Genocea Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genocea Biosciences. If investors know Genocea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genocea Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Genocea Biosciences is measured differently than its book value, which is the value of Genocea that is recorded on the company's balance sheet. Investors also form their own opinion of Genocea Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Genocea Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genocea Biosciences' market value can be influenced by many factors that don't directly affect Genocea Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genocea Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Genocea Biosciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genocea Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.